ScienceDex / Researcher record
Smith, James Leif
- Sano Chemicals, Inc (no department on record)
From the FY2021 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
NIH Funding · FY2021
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2009 | $34,324 | 1 | #43,456 |
| 2016 | $295,381 | 1 | #27,054 |
| 2017 | $459,109 | 2 | #17,757 |
| 2019 | $983,345 | 1 | #8,405 |
| 2020 | $965,515 | 1 | #3,113 |
| 2021 | $930,515 | 1 | #10,203 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20091 record
- FY20161 record
- FY20172 records
- FY20191 record
- FY20201 record
- FY2021 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2009 through FY2021Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2021 award records by amount
NIH award records listing Smith, James Leif as a PI. Multi-PI records show the full award amount for context.
- 5R42AI131792-04R42Contact PIPreclinical Development of OCF001 for Treatment of Yeast Infections$930.5Kaward amount
Award organization
Organizations that administered FY2021 awards listing Smith, James Leif as a PI.
FY2021 award administered by Sano Chemicals, Inc (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2009First NIH AwardSano Chemicals, Inc
- 2017$500K Cumulative Funding
- 2019$1M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #8405
- 2020$2M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #3113